Archives

by in
Entry Author Date Location
Diagnosis On-demand: Methodist Develops V-chip Medtech Device 04/11/14 Texas
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
PharmAthene Backs Out of Theraclone Sciences Merger 12/02/13 Seattle
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Theraclone Merges With PharmAthene, Plans to Stay in Seattle 08/01/13 Seattle
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
The Holy Grail of Drug Development: Small Molecules with the Power of Biologics 02/14/13 Boston
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Genentech, ImmunoGen Souped-Up Breast Cancer Drug Extends Lives 10/01/12 San Francisco
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus 06/14/12 Seattle
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
SD Biotech Roundup: Elevation Pharmaceuticals, BioSurplus, and More 05/17/12 San Diego
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
Page 1 of 4 next page »